Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 37.5438.9425.3832.8950.80

What is the latest EV/EBIT ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest EV/EBIT ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 37.54 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202537.54
Mar202438.94
Mar202325.38
Mar202232.89
Mar202150.80

How is EV/EBIT of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2025 37.54
-3.60
Mar2024 38.94
53.43
Mar2023 25.38
-22.83
Mar2022 32.89
-35.26
Mar2021 50.8 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare EV/EBIT ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹39,327.9 Cr -2.4% -12% -19.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,645.0 Cr 2.9% 3.6% 0.2% Stock Analytics
DIVIS LABORATORIES ₹159,625.0 Cr 0.6% -4.5% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,415.0 Cr 2.1% -0.4% 31.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,664.0 Cr 2.2% -0.4% 6.2% Stock Analytics
CIPLA ₹100,480.0 Cr 0.4% -6.2% -19.4% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-2.4%

-12%

-19.3%

SENSEX

-1.9%

-9.1%

-0.2%


You may also like the below Video Courses